Ann: Acrux's fourth generic dossier accepted by FDA for review, page-7

  1. 6,598 Posts.
    lightbulb Created with Sketch. 53
    it had nothing to do with the news. I think that most have no idea what drugs ACR currently has marketed or in review. If the chart says buy, they buy, says sell, the dump. The whole process is driven by volume and momentum. ACR are on their way to a much better future. Hopefully our partners get quicker results with the FDA. The up side is once developed a generic drug can last decades in production.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
-0.001(5.56%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.8¢ 1.9¢ 1.7¢ $8.809K 495.6K

Buyers (Bids)

No. Vol. Price($)
5 266679 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 252359 2
View Market Depth
Last trade - 14.49pm 24/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.